These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 30551640)
21. Sotrastaurin attenuates the stemness of gastric cancer cells by targeting PKCδ. Yuan Y; Yangmei Z; Rongrong S; Xiaowu L; Youwei Z; Sun S Biomed Pharmacother; 2019 Sep; 117():109165. PubMed ID: 31261030 [TBL] [Abstract][Full Text] [Related]
22. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer. Glackin CA Enzymes; 2018; 44():83-101. PubMed ID: 30360816 [TBL] [Abstract][Full Text] [Related]
23. Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer. Mu C; Wu X; Zhou X; Wolfram J; Shen J; Zhang D; Mai J; Xia X; Holder AM; Ferrari M; Liu X; Shen H Clin Cancer Res; 2018 Oct; 24(19):4900-4912. PubMed ID: 29921732 [No Abstract] [Full Text] [Related]
24. Insights into new mechanisms and models of cancer stem cell multidrug resistance. Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817 [TBL] [Abstract][Full Text] [Related]
25. Targeting Cancer Stemness in the Clinic: From Hype to Hope. Saygin C; Matei D; Majeti R; Reizes O; Lathia JD Cell Stem Cell; 2019 Jan; 24(1):25-40. PubMed ID: 30595497 [TBL] [Abstract][Full Text] [Related]
26. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling. Chang MT; Lee SP; Fang CY; Hsieh PL; Liao YW; Lu MY; Tsai LL; Yu CC; Liu CM Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235 [TBL] [Abstract][Full Text] [Related]
28. Cancer stem cells and chemoresistance: The smartest survives the raid. Zhao J Pharmacol Ther; 2016 Apr; 160():145-58. PubMed ID: 26899500 [TBL] [Abstract][Full Text] [Related]
29. Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil. Nandi SK; Roychowdhury T; Chattopadhyay S; Basu S; Chatterjee K; Choudhury P; Banerjee N; Saha P; Mukhopadhyay S; Mukhopadhyay A; Bhattacharya R Toxicol Appl Pharmacol; 2022 Feb; 437():115887. PubMed ID: 35063459 [TBL] [Abstract][Full Text] [Related]
30. Cancer stem cells targeting agents--a review. Shi AM; Tao ZQ; Li H; Wang YQ; Zhao J Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4064-7. PubMed ID: 26592827 [TBL] [Abstract][Full Text] [Related]
31. ZnAs@SiO Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768 [No Abstract] [Full Text] [Related]
32. Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells. Wang X; Low XC; Hou W; Abdullah LN; Toh TB; Mohd Abdul Rashid M; Ho D; Chow EK ACS Nano; 2014 Dec; 8(12):12151-66. PubMed ID: 25437772 [TBL] [Abstract][Full Text] [Related]
33. Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance. Ward Rashidi MR; Mehta P; Bregenzer M; Raghavan S; Fleck EM; Horst EN; Harissa Z; Ravikumar V; Brady S; Bild A; Rao A; Buckanovich RJ; Mehta G Neoplasia; 2019 Aug; 21(8):822-836. PubMed ID: 31299607 [TBL] [Abstract][Full Text] [Related]
34. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer. Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824 [TBL] [Abstract][Full Text] [Related]
36. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells. Su P; Yang Y; Wang G; Chen X; Ju Y Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726 [TBL] [Abstract][Full Text] [Related]
37. Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells. Dreaden EC; Gryder BE; Austin LA; Tene Defo BA; Hayden SC; Pi M; Quarles LD; Oyelere AK; El-Sayed MA Bioconjug Chem; 2012 Aug; 23(8):1507-12. PubMed ID: 22768914 [TBL] [Abstract][Full Text] [Related]
38. Silica coated gold nanorods for imaging and photo-thermal therapy of cancer cells. Mallick S; Sun IC; Kim K; Yil DK J Nanosci Nanotechnol; 2013 May; 13(5):3223-9. PubMed ID: 23858834 [TBL] [Abstract][Full Text] [Related]
39. Cancer Stem Cells and Targeting Strategies. Barbato L; Bocchetti M; Di Biase A; Regad T Cells; 2019 Aug; 8(8):. PubMed ID: 31426611 [TBL] [Abstract][Full Text] [Related]
40. Combined treatment with cisplatin and the tankyrase inhibitor XAV-939 increases cytotoxicity, abrogates cancer-stem-like cell phenotype and increases chemosensitivity of head-and-neck squamous-cell carcinoma cells. Roy S; Roy S; Kar M; Chakraborty A; Kumar A; Delogu F; Asthana S; Hande MP; Banerjee B Mutat Res Genet Toxicol Environ Mutagen; 2019 Oct; 846():503084. PubMed ID: 31585633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]